Michel, Maurice
Spinelli, Francesca
Grambihler, Annette
Labenz, Christian
Nagel, Michael
Kaps, Leonard
Huber, Yvonne
Galle, Peter R.
Wörns, Marcus-Alexander
Schattenberg, Jörn M. http://orcid.org/0000-0002-4224-4703
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Accepted: 16 April 2021
First Online: 12 May 2021
Declarations
:
: JMS has acted as consultant to Boehringer Ingelheim, BMS, Genfit, Gilead Sciences, Intercept Pharmaceuticals, Madrigal, Novartis, Novo Nordisk, Nordic Bioscience, Pfizer, Roche, Sanofi, Siemens Healthcare GmbH. Research Funding: Gilead Sciences, Boehringer Ingelheim. Speakers Bureau: Falk Foundation MSD Sharp & Dohme GmbH. The other authors have no conflicts of interest to declare.